These past few years have marked the acceleration of the adoption of in silico techniques for more efficient and innovative clinical research. When embarking on a new R&D program, scientists face a strategic imperative to assemble the best and most relevant available data and insights. Jinkō, Novadiscovery’s in silico clinical trial simulation platform, has been designed to build and maintain a high-quality knowledge repository, allowing teams to seamlessly cooperate, both internally and with external thought leaders. During the first part of this webinar, featured speaker Dr. Friehs, will explain her role and how she uses jinkō with her fellows to extract, classify and qualify pieces of knowledge in a systematic, transparent and traceable manner, and use these in research reports and literature reviews. After that, featured speaker Frédéric (CPO of Novadiscovery) will showcase how this knowledge is then leveraged directly within jinkō to help lower cost and ethical constraints as well as achieve greater trial efficiency through the design and simulation of in silico trials. This will be illustrated with two practical use cases using Nova’s non-small cell lung cancer (NSCLC) disease model of epidermal growth factor receptor (EGFR) mutated lung adenocarcinoma (LUAD). First, by exploring a large range of doses and then by testing eligibility criteria refinement and its impact on treatment effectiveness. Join this webinar to learn more about using a clinical trial simulation platform to generate auditable and reproducible digital evidence.
Join this webinar to learn more about using an in silico clinical trial simulation platform to generate auditable and reproducible digital evidence.
Randomization and trial supply management (RTSM) and electronic data capture (EDC) technologies and systems are essential to managing clinical trials. As clinical trials become increasingly complex, biostatisticians become even more essential, providing the needed insight to understand protocol-specific randomization nuances and make optimal randomization decisions to improve trial outcomes. In this case study-focused webinar, the featured speakers will highlight how biostatistics is crucial at multiple stages of clinical trials such as study design, randomization implementation, rerandomization needs, randomization and drug supply checks, unblinding and final analysis.
AiCure’s Clinical Site Services team partners with sites and sponsors throughout research and empowers site operations with actionable, data-driven guidanceAiCure expands its leadership team to drive …
Rochester, Minn.-based Mayo Clinic will use blockchain technology from Triall in an upcoming clinical trial studying pulmonary hypertension, the tech company said Sept. 1.
The technology will be used …
H1, the connecting force for global HCP, clinical, scientific, and research information, and Lokavant, the leading clinical trial intelligence company, today announced an extensive data-and-analytics …
The lack of diversity in clinical trials unfairly skews American medicine and costs billions of dollars a year in early deaths and poor health. The 2022 National Academies report showed that progress …
Clinical R&T 2022 forum promotes unwrap discussion of timely topics of theoretical and practical interest for clinical trial investigators who are developing new drugs and biologics. This is the unsurpassed situate to take your challenges and opportunities to the industry's forefront and work together with your industry colleagues to find solutions. The two-day conference will provide modern information and tools, best practices and education to ensure that your training in clinical research is advanced. Conferences are vital forum for academic researchers and business leaders. "It involves multiple presentations, interactive breakout sessions, hands-on product demonstrations and unrivalled networking opportunities". We have invited some of the world's most sought-after keynote speakers, experts, brand ambassadors, and industry leaders to share their thoughts and ideas with our conference guests.
Here are some ways decentralized clinical trials have the potential to improve participation rates across difficult-to-enroll populations.
We have a moral and scientific obligation to expand access so …
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our